In 2022, 81,806 opioid-involved overdose deaths were reported in the United States, more than in any previous year. Medications for opioid use disorder (OUD), particularly buprenorphine and methadone, substantially reduce overdose-related and overall mortality. However, only a small proportion of persons with OUD receive these medications. Data from the 2022 National Survey on Drug Use and Health were applied to a cascade of care framework to estimate and characterize U.S. adult populations who need OUD treatment, receive any OUD treatment, and receive medications for OUD. In 2022, 3.7% of U.S. adults aged ≥18 years needed OUD treatment. Among these, only 25.1% received medications for OUD. Most adults who needed OUD treatment either did not perceive that they needed it (42.7%) or received OUD treatment without medications for OUD (30.0%). Compared with non-Hispanic Black or African American and Hispanic or Latino adults, higher percentages of non-Hispanic White adults received any OUD treatment. Higher percentages of men and adults aged 35–49 years received medications for OUD than did women and younger or older adults. Expanded communication about the effectiveness of medications for OUD is needed. Increased efforts to engage persons with OUD in treatment that includes medications are essential. Clinicians and other treatment providers should offer or arrange evidence-based treatment, including medications, for patients with OUD. Pharmacists and payors can work to make these medications available without delays.
IntroductionIn 2022, more opioid-involved overdose deaths (81,806) were reported in the United States than in any previous year.* Medications for opioid use disorder (OUD) include buprenorphine, methadone, and extended-release naltrexone. These medications, especially buprenorphine and methadone, substantially reduce overdose-related and overall mortality but are markedly underused[1,2]. Using an OUD cascade of care framework adapted from HIV care delivery improvement efforts[2], National Survey on Drug Use and Health (NSDUH) data were used to estimate and characterize U.S. adult populations who 1) need OUD treatment, 2) perceive a need for OUD treatment, 3) receive any OUD treatment, and 4) receive medications for OUD.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3